News

Acquisition of Nicox’s US ophthalmic diagnostics subsidiary by Valeant

Valeant Pharmaceuticals International, Inc. has acquired Nicox’s US diagnostics subsidiary Nicox Inc., in a deal worth up to $20 million. Nicox intends to concentrate its commercial and development resources on ophthalmic therapeutics.

Read more